Navigation Links
Two Biotech Companies Join Science Center’s Port Community
Date:12/12/2013

Philadelphia, PA (PRWEB) December 12, 2013

Two new biotechnology companies, Targeted Therapeutic Solutions, LLC and Innolign Biomedical, LLC have begun operations at the University City Science Center’s Port business incubator at 3711 Market Street, in Philadelphia.

Both startups launched as part of the University of Pennsylvania’s UPstart Program. They will utilize laboratory and office space at the Science Center to pursue product research and development programs. They have each received Phase 1 Small Business Innovation Research (SBIR) funding from the National Institutes of Health.

Targeted Therapeutic Solutions LLC (TTS), is currently developing one of their lead technologies, a unique agent that can potentially reduce the incidence of stroke and its associated maladies. This therapeutic approach has the potential for reducing bleeding risk than existing clinical agents, making this technology useful for patients with or at risk for pulmonary embolism, deep vein thrombosis and certain types of heart attacks.

Innolign Biomedical is a biotechnology company utilizing its novel microfabrication technologies and expertise in tissue engineering to develop high throughput organ-on-chip assessment platforms for the pharmaceutical industry and to design novel biomaterials as products for promoting therapeutic tissue regeneration.

“These two new companies complement the diverse composition of the Science Center’s Port incubator,” Science Center Vice President Science & Technology Christopher J. Laing, MRCVS, Ph.D., said. “The University of Pennsylvania’s UPstart Program is creating an exciting pipeline of startups in biotech and emerging technologies. We are delighted to provide an ecosystem that will allow these companies to continue to grow.”

As of Dec. 1, the 45 current residents of the Port include startups in life sciences, healthcare, IT, emerging technologies and support organizations. Combined, they deploy more than $27 million in risk capital, and employ 92 people.

About the Science Center
The University City Science Center is a dynamic hub for innovation, entrepreneurship and technology development in the Greater Philadelphia region. Its Port facility provides business incubation, programming, lab and office facilities and support services for entrepreneurs, startups, growing and established companies. The Science Center was the first, and remains the largest, urban research park in the United States. Since it was founded in 1963, graduate organizations and current residents of the Port business incubator have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually. The Science Center is celebrating its 50th anniversary in 2013. For more information, visit sciencecenter.org.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11415515.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. Puma Biotechnology Announces Completion of Private Placement
3. Animal Biotechnology - Technologies, Markets and Companies
4. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
5. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
9. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
10. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
11. Selexis SA to Present at Biotech Showcase 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... ... April 26, 2016 , ... ... systems, announces the latest technology innovation for its Volume Pattern Generator (VPG) line ... for production of advanced photomasks as well as a solution for mid volume ...
(Date:4/26/2016)... Seattle, Washington (PRWEB) , ... April 26, 2016 ... ... (IVS) today announced receipt of a significant operating grant from 1Plus12 Corporation. The ... and to commence pre-proposal activities as outlined on the organization's website http://www.ivsci.org ...
(Date:4/26/2016)... 26, 2016 genae, a Contract ... industries, announced today the appointment of Prof. Dr. Jörn ... Balzer,s responsibilities will include all clinical, safety and risk ... feel privileged and honored with the acceptance of Prof. ... , CEO at genae. "Prof. Balzer,s impressive and extensive ...
(Date:4/26/2016)... ... April 26, 2016 , ... Smarter Alloys™ today ... is available for purchase in the United States through the official online store ... our partners, we’re excited to finally make the most advanced archwire in the ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):